📰 Immunic News
Page 3 - Immunic News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Immunic. Real-time updates on events, politics, business and more.
July 28, 2023
Wedbush reiterated their outperform rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report issued on Thursday morning, Benzinga reports. Wedbush currently has a $5.00 price target on the stock. Separately, StockNews.com began coverage on Immunic in a research report on Thursday, May 18th. They issued a sell rating on the stock. One […]
July 27, 2023
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
July 24, 2023
Key Insights Institutions' substantial holdings in Immunic implies that they have significant influence over the...
July 21, 2023
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 2,170,000 shares, a growth of 6.9% from the June 15th total of 2,030,000 shares. Based on an average daily volume of 1,040,000 shares, the […]
June 29, 2023
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
June 5, 2023
Vivo Capital LLC acquired a new stake in shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 632,184 shares of the company’s stock, valued at approximately $833,000. Vivo Capital LLC owned approximately […]
June 1, 2023
Any one member to move to vacate the chair. listen to ken buck. >> the discussion about the motion to vacate is going to happen in the next week or two. >> what would your reaction be if democrats were to step in and save mccarthy? he told us hes open. >> its like a date with a munic. >> elaborate? >> he does not have much power when he relies on democrats to keep him as speaker. >> is that real? meaning there will be a real challenge to mccarthys leadership. i assume he would survive it, or is ...
May 30, 2023
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...
May 30, 2023
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Investor Conferences in June NEW YORK,...
May 30, 2023
Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in June 30.05.2023 / 12:30 CET/CEST The issuer is solely responsible